NCT04397406View on ClinicalTrials.gov

Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Epidural AnalgesiaPainless LaborDexmedetomidineFentanylLevobupivacaine
Interventions
DRUG

levobupivacaine

The patients will receive 15 ml of 0.125% levobupivacaine.

DRUG

Dexmedetomidine

The patients will receive 13 ml of 0.125% levobupivacaine and 0.5μg/kg dexmedetomidine diluted in 2 ml saline.

DRUG

Fentanyl

The patients will receive 13 ml of 0.125% levobupivacaine and 25μg fentanyl diluted in 2 ml saline.

Trial Locations (1)

31527

Tanta University Hospitals, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04397406 - Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor | Biotech Hunter | Biotech Hunter